Urolithin A vs L-Carnitine: Moving Fuel vs Renewing the Engine

Reviewed by SOMA HEALTH's Medical Research Team

L-carnitine and urolithin A both get talked about as ‘mitochondrial’ supplements, which makes them sound interchangeable. They are not. The cleanest way to hold the difference in your head is this: L-carnitine helps move fuel into your mitochondria, while SOMA HEALTH Urolithin A supports the health and renewal of those mitochondria themselves. One is about transport. The other is about maintenance. This guide walks through both, honestly.

Full disclosure first: SOMA HEALTH sells a urolithin A product, so we are a competitor in this space and we have a commercial interest. We have kept the comparison as even-handed as we can, separated proven human research from early preclinical work, and been clear about what neither compound is meant to do.

What L-carnitine does: moving the fuel

L-carnitine is a compound your body makes from the amino acids lysine and methionine, and it also comes from foods such as red meat. Its best-established role is as a shuttle. Long-chain fatty acids cannot cross the inner mitochondrial membrane on their own; L-carnitine, working with the enzymes carnitine palmitoyltransferase I and II, ferries those fats inside so they can be burned for energy through beta-oxidation. In short, carnitine is a transport molecule that keeps the fatty-acid fuel line moving into the mitochondrion.

You will see it sold as plain L-carnitine, acetyl-L-carnitine and L-carnitine L-tartrate. The human evidence is genuinely mixed. Some studies suggest a role in exercise recovery and reducing markers of muscle stress, and carnitine is clinically important in people with a true deficiency. But the popular idea that a scoop of carnitine reliably melts body fat in healthy, well-nourished people is not well supported — and raising muscle carnitine content through supplementation appears to be slow and to depend on carbohydrate intake. It is a useful, well-characterized molecule, but it is not a renewal compound.

What urolithin A does: renewing the engine

Urolithin A (UA) works on a different layer entirely. It does not shuttle fuel; it supports mitophagy — the quality-control process by which cells tag worn-out or damaged mitochondria and recycle them, making room for newer, better-functioning ones. If carnitine is about keeping fuel flowing into the engine, urolithin A is about keeping the engines themselves in good repair. Over time, mitophagy tends to slow down, and that decline is one reason mitochondrial function tends to fade with age.

Urolithin A is also unusual in where it comes from. It is a postbiotic: your gut bacteria produce it when they break down ellagitannins, polyphenols found in pomegranate, walnuts and some berries. The wrinkle is that only some people carry the microbes needed to make meaningful amounts, so eating those foods does not guarantee you produce it. That is the core reason a standardized, direct dose exists. For the deeper mechanism, see our urolithin A guide and our overview of mitochondrial health.

What the human research on urolithin A shows

We cite only studies we can point to, and we label each as human or preclinical. Here is the human evidence, from most established to newest.

Proven, well-established human findings

The first-in-human study (Andreux and colleagues, Nature Metabolism, 2019) found urolithin A was safe and well tolerated in healthy older adults at doses up to 1,000 mg per day and produced a measurable mitochondrial gene-expression signature. A randomized trial in older adults (Liu, D’Amico and colleagues, JAMA Network Open, 2022) over about four months reported improved muscle endurance. A randomized trial in middle-aged adults (Singh and colleagues, Cell Reports Medicine, 2022), with 500 mg and 1,000 mg daily arms over four months, reported benefits for muscle strength and exercise performance.

Newer human findings

An 8-week randomized controlled trial in resistance-trained men (Journal of the International Society of Sports Nutrition, 2024) studied urolithin A alongside training. A 2025 randomized controlled trial (Nature Aging), running roughly 28 days, reported support for the mitochondrial health of immune cells in midlife adults, relevant to ‘inflammaging.’ A 2025 trial in distance runners adds further human data. Notice the pattern: much of the human signal sits in muscle, exercise capacity and cellular energy — adjacent to, but mechanistically distinct from, what carnitine transport addresses.

Honest limitations

A 2024 systematic review in Ageing Research Reviews concluded the human evidence for targeting aging with urolithin A is still emerging. Trials are relatively short, samples are modest, and the strongest findings are in muscle and mitochondrial endpoints rather than sweeping whole-body claims. Urolithin A is a well-tolerated compound with a specific mechanism — not a proven cure-all.

Where urolithin A research is still early (preclinical)

Some of the most eye-catching findings are preclinical and should be read that way. The foundational work (Ryu and colleagues, Nature Medicine, 2016) showed mitophagy activation, extended lifespan in the worm C. elegans, and improved muscle function in rodents — animal and lab models, not humans. Osteoarthritis-model work (D’Amico and colleagues, Aging Cell, 2022) explored joint and cartilage effects preclinically. For skin, gut, brain and heart, early or preclinical research is exploring possible roles, without human confirmation yet.

Which one, and do they overlap?

Because they act on different steps, L-carnitine and urolithin A are not really substitutes for each other. If your interest is fatty-acid transport and exercise recovery, carnitine is the molecule built around that question — with the caveat that its human results are mixed and it matters most where a deficiency exists. If your interest is the age-related decline in mitochondrial quality control, urolithin A is the compound with human trials pointed at mitophagy and muscle function. Some people who train hard or care about healthy aging look at both; there is no established interaction concern, but that is a conversation to have with a clinician rather than to assume.

If you are weighing urolithin A specifically, our pages on urolithin A for muscle and urolithin A dosage go deeper, and to compare finished products see our roundup of the best urolithin A gummies.

The SOMA HEALTH product, briefly

SOMA HEALTH Urolithin A Gummies provide 1,000 mg of urolithin A per 4-gummy daily serving — the top of the studied 500–1,000 mg range. Each bag holds 120 gummies for a 30-day supply. They are raspberry-flavored, sugar-free and third-party tested, at $79. It is a single-compound product built to deliver a clinically studied urolithin A dose — it is not a carnitine product and does not aim to do carnitine’s transport job.

Explore SOMA HEALTH Urolithin A Gummies

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.